Madrigal Pharmaceuticals inc. buy BiotechBee
Start price
23.02.25
/
70%
€318.40
Target price
31.12.26
€400.00
Performance (%)
49.47%
End price
21.11.25
€475.90
Summary
This prediction ended on 21.11.25 with a price of €475.90. With a performance of 49.47% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Madrigal Pharmaceuticals inc. | -1.816% | -1.816% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to BiotechBee what are the pros and cons of Madrigal Pharmaceuticals inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Madrigal Pharmaceuticals inc. diskutieren
Buy mit Kursziel 400,0
In the thread Trading Madrigal Pharmaceuticals inc.
Stopped prediction by BiotechBee for Madrigal Pharmaceuticals inc.
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€305.00
19.01.25
19.01.25
€380.00
30.11.27
30.11.27
4.39%
23.02.25
23.02.25
Could be very worthwhile Investment >20% year
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€214.90
24.06.23
24.06.23
€380.00
31.05.26
31.05.26
33.50%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€66.50
30.09.22
30.09.22
€120.00
31.12.24
31.12.24
324.36%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year